CARPRODOLOR 50 MG/ML SOLUTION INJECTABLE POUR BOVINS
Nchi: Ufaransa
Lugha: Kiingereza
Chanzo: HMA (Heads of Medicines Agencies)
Tabia za bidhaa
(SPC)
24-09-2013
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
carprofen 50 mg/ml
Inapatikana kutoka:
Le Vet B.V
ATC kanuni:
QM01AE91
Dawa fomu:
Solution for injection
Kundi la matibabu:
carprofen
Eneo la matibabu:
Cattle
Idhini ya tarehe:
2013-01-23
Tabia za bidhaa
Issued: May 2013
AN: 01920/2011
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Carprodolor 50 mg/ml solution for injection for cattle
Carprodolor vet. 50 mg/ml solution for injection for cattle (FI)
Carprosan 50 mg/ml solution for injection for cattle (ES, PT)
Carprosan vet. 50 mg/ml solution for injection for cattle (NO, SE, DK, IS)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Per ml:
ACTIVE SUBSTANCE:
Carprofen
50 mg
EXCIPIENT(S):
Ethanol 96%
0.1 ml
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for Injection
Clear pale straw coloured liquid
4.
CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle
4.2 INDICATIONS FOR USE,SPECIFYING THE TARGET SPECIES
The product is indicated as an adjunct to antimicrobial therapy to reduce clinical
signs in acute infectious respiratory disease and acute mastitis in cattle.
4.3 CONTRAINDICATIONS
Do not use in animals suffering from cardiac, hepatic or renal impairment.
Do not use in animals suffering from gastro-intestinal ulceration or bleeding.
Do not use where there is evidence of a blood dyscrasia.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.
Issued: May 2013
AN: 01920/2011
Page 2 of 6
4.4 SPECIAL WARNINGS
None
4.5 SPECIAL PRECAUTIONS FOR USE
I.
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there
is a potential risk of increased renal toxicity. Concurrent administration of
potentially nephrotoxic drugs should be avoided.
Do not exceed the stated dose or the duration
Soma hati kamili
